Shifting LRP1 transport towards transcytosis, increasing its levels, and enhancing LRP1-dependent Aβ efflux from the brain significantly reduces amyloid load and restores cognitive function in animals, with the therapeutic effect persisting for an extended period [31]. This evidence concerns the gene LRP1 and amyloidosis.